RNXT_IR_Deck_May_2024

Loading viewer...

investor_presentation

Format: PDF investor_presentation

This corporate presentation by RNXT outlines their late-clinical stage biopharmaceutical developments, focusing on pancreatic cancer therapies and future strategies.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from RNXT

View all →

investor_presentation

investor_presentation

Similar investor_presentations from other companies

Browse all →

Ethos Limited Q4 FY22 Investor Presentation May 2022

investor_presentation

44 Pages

Ethos Limited

SLM Corporation 4th Quarter 2023 Investor Presentation

investor_presentation